Safety and Tolerability of Aminaphtone in Systemic Sclerosis Patients: A Four-year Follow-up

Authors
Category Primary study
ConferenceArthritis and Rheumatology
Year 2022
This article has no abstract
Epistemonikos ID: 177b60ddaf04d6d000924aa9a7adca755a518d83
First added on: Apr 30, 2026